AETHLON MEDICAL INC (AEMD)
US00808Y4061 - Common Stock
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Aethlon Medical gets new chief head (NASDAQ:AEMD)
Aethlon Medical announced the appointment of James B. Frakes as interim CEO and CFO, replacing Charles J. Fisher, Jr., M.D.
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening viral...
Aethlon Medical to effect 1-for-10 reverse stock split to meet Nasdaq rules (NASDAQ:AEMD)
Aethlon Medical announces a 1-for-10 reverse stock split to meet Nasdaq rules, with ~2.5M shares issued and outstanding.
Aethlon Announces Reverse Stock Split
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon evaluating use of Hemopurifier device in organ transplantation (AEMD)
Aethlon Medical (AEMD) said it is investigating using its Hemopurifier device to remove harmful viruses and exosomes from organs harvested for transplantation. Read more here.
Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic with traders on Thursday as we go over the shares seeing the biggest movements this morning.
Aethlon Medical to Present at the 13th Annual LD Micro Invitational
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and...
Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life...
Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update
/PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life...
Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023
/PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...